IP Library Granted Patent US 7,112,335
Granted Patent B2
US 7,112,335 · App. 11/219,960 · Granted Sep 26, 2006

Minimally compliant, volume-efficient piston for osmotic drug delivery systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,112,335
App. No.
11/219,960
Granted
Sep 26, 2006
Kind
B2
Abstract

An osmotic pump having a minimally compliant, volume-efficient piston positioned within a capsule is provided. The capsule has an interior surface, a beneficial agent, and an osmotic agent. The piston is movable with respect to an interior surface of the capsule, and defines a movable seal with the interior surface of the capsule. The movable seal separates the osmotic agent from the beneficial agent. The piston has a length-to-total-diameter ratio of about 1.1:1 and a core-diameter-to-total-diameter ratio of about 0.9:1. The piston enables greater beneficial agent and/or osmotic agent payload without increasing the size of the capsule. The osmotic agent imbibes liquid from a surrounding environment through a semipermeable body to cause the piston to move and, in turn, cause delivery of the beneficial agent from the capsule.

Claims (27)

1. An osmotic delivery system comprising:

a capsule having an interior for holding a beneficial agent;

an osmotic agent located in the interior; and

a movable piston having a length to total diameter ratio of about 1.1:1 and a core diameter to overall diameter ratio of about 0.9:1 located within the interior of the capsule, defining a seal with an interior surface of the capsule that separates the osmotic agent from the beneficial agent.

2. The osmotic delivery system according to claim 1 , wherein the piston includes one or a plurality of ribs for effecting the seal with the interior surface.

3. The osmotic delivery system according to claim 1 , wherein the capsule includes a cylindrical tube.

4. The osmotic delivery system according to claim 3 , wherein the cylindrical tube includes an opening and further includes a semipermeable body within the opening.

5. The osmotic delivery system according to claim 1 , wherein the osmotic agent includes a tablet.

6. An osmotic delivery system comprising:

a piston having a length to overall diameter ratio not greater than about 1.1:1 and a core diameter to overall diameter ratio not greater than about 0.9:1;

an osmotic agent; and

an enclosure having an interior holding the piston and the osmotic agent, the piston being movable with respect to the enclosure.

7. The osmotic delivery system according to claim 6 , wherein the interior of the enclosure includes an interior surface, the piston abutting against the interior surface.

8. The osmotic delivery system according to claim 6 , further comprising a semipermeable body in liquid communication with the osmotic agent and within the enclosure.

9. The osmotic delivery system according to claim 6 , wherein the enclosure is fluid impermeable.

10. The osmotic delivery system according to claim 8 , wherein the osmotic agent is located between the semipermeable body and the piston.

11. The osmotic delivery system according to claim 6 , further comprising a beneficial agent located in the interior of the enclosure, the beneficial agent being delivered from the enclosure when the piston moves.

12. The osmotic delivery system according to claim 6 , wherein the piston is fluid impermeable.

13. The osmotic delivery system according to claim 6 , wherein the piston includes at least one rib for effecting a movable seal with the enclosure.

14. The osmotic delivery system according to claim 6 , further comprising a beneficial agent located in the interior of the enclosure, the piston defining a movable seal that separates the osmotic agent from the beneficial agent.

15. An osmotic delivery system comprising:

a capsule having a tubular interior, the tubular interior having an interior surface;

a semipermeable body located at least partially within the tubular interior;

an osmotic agent located between the semipermeable body and a piston;

a beneficial agent located within the tubular interior; and

a piston located within the tubular interior, the piston having a length to overall diameter ratio less than about 1.1:1 and a core diameter to overall diameter ratio less than about 0.9:1, the piston separating the beneficial agent from the osmotic agent, and being movable with respect to the interior surface of the tubular interior and with respect to the semipermeable body.

16. The osmotic delivery system according to claim 15 , wherein the piston includes at least one rib.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
Reel/Frame 052433/0001 →
RELEASE OF SECURITY INTEREST Recorded Jan 29, 2020
From: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C. AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 051739/0453 →
SECURITY INTEREST Recorded Oct 23, 2019
From: INTARCIA THERAPEUTICS, INC.
To: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C., AS COLLATERAL AGENT
Reel/Frame 050801/0267 →
SECURITY INTEREST Recorded Oct 9, 2019
From: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050673/0020 →
RELEASE OF SECURITY INTEREST Recorded Oct 23, 2015
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 036942/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2015
From: LAUTENBACH, SCOTT D.
To: ALZA CORPORATION
Reel/Frame 035256/0175 →
SECURITY AGREEMENT Recorded Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
SECURITY AGREEMENT Recorded Sep 8, 2010
From: INTARCIA THERAPEUTICS, INC.
To: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
Reel/Frame 024953/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020035/0441 →